References
- von Gierke E. Hepato-nephromegalia glykogenica. Betir Pathol Anat Allg Pathol 1929; 82: 497–513
- Chen Y T, Coleman R A, Schienman J L. Renal disease in type I glycogen storage disease. N Engl J Med 1988; 318: 7–11
- Obara K, Saito T, Sato H. Renal histology in 2 adult patients with type 1 glycogen storage disease. Clin Nephrol 1993; 39: 59–64
- Gehrig J J, Wolfe J A. Renal disease in type I glycogen storage disease. N Engl J Med 1988; 318: 1759–1760
- Reitsma-Bierrens W CC. Renal complications in glycogen storage disease type I. Eur J Pediatr 1993; 152(suppl 1)S60–S62
- Steim H, Zollinger H U. Toedliche Schrumpfniere bei Glykogen Speicherkrankheit Typ von Gierke. Klin Wochenschr 1967; 45: 295–299
- Chen Y T. Type I glycogen storage disease: kidney involvement, pathogenesis and its treatment. Pediatr Nephrol 1991; 5: 71–76
- Smit G PA, Fernandes J, Leonard J V. The long-term outcome of patients with glycogen storage diseases. J Inher Metab Dis 1990; 13: 411–418
- Greene H L, Slonim A E, O'Neill J A, Jr, Burr I M. Continuous nocturnal intragastric feeding for management of type I glycogen storage disease. N Engl J Med 1976; 294: 423–425
- Chen Y T, Cornblath M, Sidbury J B. Cornstarch therapy in type I glycogen storage disease. N Engl J Med 1984; 310: 171–175
- Baker L, Dahlem S, Goldfarb. Hyperfiltration and renal disease in glycogen storage disease type 1. Kidney Int 1989; 35: 1345–1350
- Reitsma W CC, Troelstra J A, van Luijk W HJ. Hyperfiltration in patients with glycogen storage disease type I. Pediatr Nephrol 1990; 4: C49
- Al-Shebeb T, Frohlich J, Magil A B. Glomerular disease in hypercholesterolemic pigs: a pathogenetic study. Kidney Int 1988; 33: 498–507
- Diamond J R, Karnovsky M J. Exacerbation of chronic aminonucleoside nephrosis by dietary cholesterol supplementation. Kidney Int 1987; 32: 671–677
- French S W, Yamanaka W, Ostwald R. Dietary induced glomerulosclerosis in the guinea pig. Arch Pathol 1967; 83: 204–210
- Wellman K F, Volk B W. Renal lesions in experimental hypercholesterolemia in normal and in subdiabetic rabbits. II. Long-term studies. Lab Invest 1971; 24: 144–145
- Kasiske B L, O'Donnell M P, Cleary M P, Keane W F. Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int 1988; 33: 667–672
- Moorhead J F, Chan M K, El-Nahas M, Varghese. Lipid nephrotoxicity in chronic progressive glomerular and tubulointerstitial disease. Lancet 1982; II: 1309–1311
- Faraggiana T, Churg J. Renal lipidoses: a review. Hum Pathol 1987; 18: 621–679
- Saito T, Sato H, Kudo K. Lipoprotein glomerulopathy: glomerular lipoprotein thrombi in a patient with hyperlipoproteinemia. Am J Kid Dis 1989; 13: 148–153
- Baker L, Kern E FO, Olshan J. Pilot study of captopril in patients with renal disease associated with glycogen storage disease type I [GSD-I]. Pediatr Res, 23: 388A